Objective:To investigate the clinical effects of Shuxuening combined with edaravone treatment for acute cerebral infarction.Method: One hundred and tweenty patients with acute cerebral infarction were randomly divided into the combined treatment group and control group（n=60 each）.The patients in the combined group were given Shuxuening with edaravone

the patients in the control group were given edaravone.The changes in neurological deficit scores（NDS） were investigated after two weeks of treatment

and the clinical efficacy was compared.Result: Before and after treatment

NDS scores were（22.5 ±4.15） and（16.71 ±4.82） in the combination group

while they were（23.1±3.99） and（19.12±3.94）in the control group.The difference after the treatment between the two groups was statistically significant（P<0.05）.The clinical efficacy was 88.3% in combined treatment group

73.3% in the control group

the difference was significant（P<0.05）.Conclusion: Shuxuening combined with edaravone therapy for patients with acute cerebral infarction is effective.The therapy may reduce the extent of nerve damage without significant side effects.